Marijuana firm Village Farms regains Nasdaq compliance; Weedmaps loses it
Marijuana company Village Farms International is back in compliance with Nasdaq rules; Weedmaps parent company WM Technology is noncompliant.
marijuana stocks
Cannabis and the capital markets: Q&A with Canadian Securities Exchange CEO Richard Carleton
Canadian Securities Exchange CEO Richard Carleton discusses the CSE’s place in the capital markets, the tough landscape for publicly traded cannabis companies and the potential impact of U.S. rescheduling.
Produce and marijuana operator Village Farms gets Nasdaq share price warning
Produce and marijuana company Village Farms International has been warned by the Nasdaq stock exchange about its low share price.
Marijuana company Organigram gets Nasdaq share-price warning
The Nasdaq stock exchange has warned Canadian marijuana cultivator and manufacturer Organigram Holdings about its share price, which has fallen below Nasdaq’s $1 minimum bid price requirement for 30 days in a row.
US marijuana stocks up in early trading on midterm election results
Shares of publicly traded U.S. marijuana companies mostly gained value Wednesday morning after the 2022 midterm elections, despite mixed results among the five state MJ ballot measures put to voters.
US, Canadian marijuana stocks surge, decline after Biden announcement
Shares of publicly traded cannabis companies surged late Thursday and then declined Friday morning after U.S. President Joe Biden’s surprise announcement that he would direct the government to review the federal drug scheduling of marijuana and issue pardons for federal MJ-possession offenses.
JPMorgan Chase to restrict purchases of cannabis-related stocks, report says
Banking giant JPMorgan Chase & Co. informed its brokerage clients they’ll no longer be allowed to purchase cannabis-related stocks and securities starting Nov. 8.
Post-election marijuana stock price moves show benefit of public liquidity
While marijuana legalization was a major winner in the U.S. general election, Canadian firms appear to be reveling in the post-election boost more than U.S. cannabis companies.
